Additionally, the median OS of patients with pediatric-type diffuse gliomas (the other IDH-wildtype gliomas in this study) was 55.1 months, significantly longer than that of patients with mol-GBMs (p=0.006). This evidence concerns the gene IDH2 and glioma.